Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$8.51 USD
-0.51 (-5.65%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $8.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 36% (90 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | 0.19 | -2.04 | 59.00 |
Year Ago Quarter Estimate | 0.25 | -0.59 | 50.37 |
Next Quarter Estimate | 0.23 | -2.00 | 60.00 |
Next Year Estimate | 0.86 | 6.92 | 238.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 111.16 | 11.30 | 20.73 |
Next Year | 22.86 | 15.60 | 13.55 |
Last 5 Years | -270.20 | 7.20 | 9.00 |
Next 5 Years | NA | 23.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 13.27 | -5.88 |
Price/Book (MRQ) | NA | 1.88 |
Price/Cash Flow (MRFY) | NA | 8.87 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -226.37% | -41.24% |
Return on Equity (TTM) | -185.45% | -39.33% |
Debt to Equity (MRQ) | -1.44 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.